Stock Comparison
ABT vs SNN
Abbott Laboratories and Smith & Nephew SNATS Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$12.63B
P/E (TTM)
35.7
20.5
Forward P/E
20.0
13.5
Price/Sales
4.1
2.0
Price/Book
3.7
2.4
EV/EBITDA
18.6
9.9
Dividend Yield
1.66%
2.60%
Profitability
Net Margin
13.91%
8.66%
Operating Margin
18.17%
13.87%
Return on Equity
10.60%
11.80%
Return on Assets
5.33%
5.16%
Growth (YoY)
Revenue Growth
13.00%
4.60%
Earnings Growth
-47.50%
5.70%
Price & Risk
Beta
0.6
0.7
52-Week High
$134.48
$37.81
52-Week Low
$82.56
$28.74
Analyst Target
$118.42
$33.88
Compare ABT and SNN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.